Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Table of contents

April 2005 - Volume 15 - Suppl 1

INTRODUCTION

Introduction to the Pre–International Gynecologic Cancer Society Roundtable Meeting: successful management of ovarian cancer (1 April, 2005)
Andreas du Bois, Robert Ozols

ARTICLES

Treatment goals in ovarian cancer (1 April, 2005)
R. F. Ozols
Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic (1 April, 2005)
M. A. Bookman
Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma (1 April, 2005)
P. G. Rose
Review of gemcitabine-based combinations for platinum-resistant ovarian cancer (1 April, 2005)
J. Sehouli
Management of platinum-sensitive relapsed ovarian cancer, with particular reference to the International Collaboration in Ovarian Neoplasm-4/Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer-2.2 trial (1 April, 2005)
S. B. Kaye
Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer (1 April, 2005)
J. Pfisterer, I. Vergote, A. Du Bois, E. Eisenhauer
Future options for first-line therapy of advanced ovarian cancer (1 April, 2005)
A. Du Bois, J. Pfisterer